Laura N. Puentes

ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells

Priyanka Verma, Yeqiao Zhou, Zhendong Cao et al. · Nature Cell Biology · 2021 · 151 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models

Mehran Makvandi, Hwan Lee, Laura N. Puentes et al. · Molecular Cancer Therapeutics · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15

TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death

Chenbo Zeng, Chi-Chang Weng, Mark E. Schneider et al. · Cell Death Discovery · 2019 · 49 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity

Sean W. Reilly, Laura N. Puentes, Khadija Wilson et al. · Journal of Medicinal Chemistry · 2018 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation

Patrick M. Glassman, Carlos H. Villa, Oscar A. Marcos‐Contreras et al. · Bioconjugate Chemistry · 2022 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +17